These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 36613838)

  • 1. The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity.
    Chulpanova DS; Rizvanov AA; Solovyeva VV
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment.
    Li X; Zhang C; Yue W; Jiang Y
    Front Immunol; 2024; 15():1362120. PubMed ID: 38962016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cancer stem cell-derived extracellular vesicles in cancer progression and metastasis.
    Naghibi AF; Daneshdoust D; Taha SR; Abedi S; Dehdezi PA; Zadeh MS; Dokoohaki F; Soleymani-Goloujeh M
    Pathol Res Pract; 2023 Jul; 247():154558. PubMed ID: 37245267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Stem Cell Initiation by Tumor-Derived Extracellular Vesicles.
    Afify SM; Hassan G; Yan T; Seno A; Seno M
    Methods Mol Biol; 2022; 2549():399-407. PubMed ID: 33755909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo.
    Brossa A; Fonsato V; Grange C; Tritta S; Tapparo M; Calvetti R; Cedrino M; Fallo S; Gontero P; Camussi G; Bussolati B
    Int J Cancer; 2020 Sep; 147(6):1694-1706. PubMed ID: 32064610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The key roles of cancer stem cell-derived extracellular vesicles.
    Su C; Zhang J; Yarden Y; Fu L
    Signal Transduct Target Ther; 2021 Mar; 6(1):109. PubMed ID: 33678805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stem Cells and Their Vesicles, Together with Other Stem and Non-Stem Cells, Govern Critical Cancer Processes: Perspectives for Medical Development.
    Meldolesi J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-stem bladder cancer cell-derived extracellular vesicles promote cancer stem cell survival in response to chemotherapy.
    Chung WM; Molony RD; Lee YF
    Stem Cell Res Ther; 2021 Oct; 12(1):533. PubMed ID: 34627375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives.
    Scioli MG; Terriaca S; Fiorelli E; Storti G; Fabbri G; Cervelli V; Orlandi A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment.
    Wu B; Shi X; Jiang M; Liu H
    Mol Cancer; 2023 Feb; 22(1):38. PubMed ID: 36810098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bench to Bedside: New Therapeutic Approaches with Extracellular Vesicles and Engineered Biomaterials for Targeting Therapeutic Resistance of Cancer Stem Cells.
    Ingavle G; Das M
    ACS Biomater Sci Eng; 2022 Nov; 8(11):4673-4696. PubMed ID: 36194142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.
    López de Andrés J; Griñán-Lisón C; Jiménez G; Marchal JA
    J Hematol Oncol; 2020 Oct; 13(1):136. PubMed ID: 33059744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
    Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
    Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation.
    Grange C; Tapparo M; Tritta S; Deregibus MC; Battaglia A; Gontero P; Frea B; Camussi G
    BMC Cancer; 2015 Dec; 15():1009. PubMed ID: 26704308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles in onco-nephrology.
    Gai C; Pomatto MAC; Grange C; Deregibus MC; Camussi G
    Exp Mol Med; 2019 Mar; 51(3):1-8. PubMed ID: 30872568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment for cancer stem cells.
    Kise K; Kinugasa-Katayama Y; Takakura N
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):197-205. PubMed ID: 26362921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells.
    Vera N; Acuña-Gallardo S; Grünenwald F; Caceres-Verschae A; Realini O; Acuña R; Lladser A; Illanes SE; Varas-Godoy M
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.